Brief: OSE Immunotherapeutics Says Board Decides Not To Appeal Court Decision
23/09/2025 21:32
Sept 23 (Reuters) - OSE Immunotherapeutics SA OSE.PA: REG-OSE IMMUNOTHERAPEUTICS ACKNOWLEDGES THE DECISION OF THE NANTES COMMERCIAL COURT OSE IMMUNOTHERAPEUTICS SA - BOARD DECIDES NOT TO APPEAL COURT DECISION Source text: ID:nGNE48khLC Further company coverage: OSE.PA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ose Immunotherapeutics SA
See all newsFactbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Brief: OSE Immunotherapeutics SA Appoints Thomas Gidoin As Deputy CEO
Brief: Ose Immunotherapeutics Will Pause Development Of OSE‑230
Brief: OSE Immunotherapeutics Gets Second Positive IDMC Nod For Phase 3 Lung Cancer Trial
Brief: OSE Immunotherapeutics Announces Appointment Of Marc Le Bozec As Interim CEO